JSAM
VCYT icon

J. Safra Asset Management’s Veracyte VCYT Stock Holding History

J. Safra Asset Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.5K Sell
281
-58
-17% -$2.43K ﹤0.01% 343
2026
Q1 		$10.9K Buy
339
+228
+205% +$8.44K ﹤0.01% 366
2025
Q4 		$4.67K Hold
111
– – ﹤0.01% 438
2025
Q3 		$3.81K Hold
111
– – ﹤0.01% 330
2025
Q2 		$3K Buy
111
+59
+113% +$1.71K ﹤0.01% 334
2025
Q1 		$1.54K Buy
+52
New +$1.98K ﹤0.01% 330

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

J. Safra Asset Management's VCYT Position: Q2 2026 in Review

J. Safra Asset Management reduced its Veracyte (VCYT) stake by 17% in Q2 2026, selling an estimated $2.43K and leaving 281 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #343.

J. Safra Asset Management first reported a position in VCYT in Q1 2025 and has held it in 6 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • J. Safra Asset Management held 281 shares of Veracyte worth $16.5K as of Q2 2026.
  • J. Safra Asset Management sold 58 Veracyte shares in Q2 2026, an estimated $2.43K.
  • Veracyte made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #343 holding.
  • J. Safra Asset Management first reported a position in Veracyte in Q1 2025 and has held it in 6 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.